J Antimicrob Chemother 2014; 69: 385 – 389
doi:10.1093/jac/dkt355 Advance Access publication 7 September 2013
Characterization of the IncA/C plasmid pSCEC2 from Escherichia coli of
swine origin that harbours the multiresistance gene cfr
Wan-Jiang Zhang1†, Xing-Ran Xu2†, Stefan Schwarz3, Xiu-Mei Wang1, Lei Dai4, Hua-Jun Zheng5 and Siguo Liu1*
1
State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agriculture, Harbin 150001,
China; 2College of Pharmaceutical Sciences of Southwest University, Chongqing 400715, China; 3Institute of Farm Animal Genetics, FriedrichLoeffler-Institut (FLI), 31535 Neustadt-Mariensee, Germany; 4Department of Veterinary Microbiology and Preventive Medicine, College of
Veterinary Medicine, Iowa State University, Ames, IA, USA; 5Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese
National Human Genome Center at Shanghai, Shanghai, China
*Corresponding author. Tel: +86-451-85935076; Fax: +86-451-82733132; E-mail: [email protected]
†These authors contributed equally to this work
Received 4 June 2013; returned 23 July 2013; revised 26 July 2013; accepted 10 August 2013
Objectives: To determine the complete nucleotide sequence of the multidrug resistance plasmid pSCEC2, isolated
from a porcine Escherichia coli strain, and to analyse it with particular reference to the cfr gene region.
Methods: Plasmid pSCEC2 was purified from its E. coli J53 transconjugant and then sequenced using the 454 GSFLX System. After draft assembly, predicted gaps were closed by PCR with subsequent sequencing of the amplicons.
Results: Plasmid pSCEC2 is 135615 bp in size and contains 200 open reading frames for proteins of ≥100 amino
acids. Analysis of the sequence of pSCEC2 revealed two resistance gene segments. The 4.4 kb cfr-containing
segment is flanked by two IS256 elements in the same orientation, which are believed to be involved in the dissemination of the rRNA methylase gene cfr. The other segment harbours the resistance genes floR, tet(A)-tetR, strA/strB
and sul2, which have previously been found on other IncA/C plasmids. Except for these two resistance gene regions,
the pSCEC2 backbone displayed .99% nucleotide sequence identity to that of other IncA/C family plasmids isolated in France, Chile and the USA.
Conclusions: The cfr gene was identified on an IncA/C plasmid, which is well known for its broad host range and
transfer and maintenance properties. The location on such a plasmid will further accelerate the dissemination
of cfr and co-located resistance genes among different Gram-negative bacteria. The genetic context of cfr on
plasmid pSCEC2 underlines the complexity of cfr transfer events and confirms the role that insertion sequences
play in the spread of cfr.
Keywords: oxazolidinone resistance, IS256 element, food-producing animals
Introduction
The transferable multiresistance gene cfr encodes an RNA methyltransferase that methylates A2503 in the 23S rRNA and thereby
mediates resistance not only to phenicols, lincosamides, pleuromutilins and streptogramin A, but also to oxazolidinones.1 This latter
aspect is of particular concern as linezolid is a last-resort antibiotic
for the treatment of infections caused by methicillin-resistant
staphylococci (in particular Staphylococcus aureus) and vancomycinresistant enterococci.2 Although most recent data suggest that cfr is
actually not widespread in clinical isolates, there are case reports of
clinical failure in the treatment of strains that carry this gene.3,4
Since its first report in a bovine Staphylococcus sciuri isolate in
2000, the cfr gene has been successively found in Bacillus spp.,
Proteus spp., Enterococcus spp., Macrococcus spp., Jeotgalicoccus
spp., Escherichia spp. and most recently in Streptococcus suis.5,6
While most reports identified the cfr gene in isolates of the abovementioned five Gram-positive genera, two reports also described
its presence in Gram-negative bacteria, namely in Escherichia coli
and Proteus vulgaris.7,8 This observation suggests not only intergenus transfer but also the transfer of cfr between Gram-positive
and Gram-negative bacteria. To date, no further information is
available about the prevalence and genetic environment of cfr in
Gram-negative bacteria. Previous studies found the cfr gene to
mostly be located on plasmids, also including several conjugative
plasmids of Gram-positive bacteria.5
In the present study, we identified a porcine E. coli isolate that
carried the cfr gene on the conjugative plasmid pSCEC2 of the
# The Author 2013. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
For Permissions, please e-mail: [email protected]
385
Zhang et al.
IncA/C family, which is known to be highly epidemic and transferable among Gram-negative bacteria. Since no information about
cfr-carrying IncA/C plasmids was available from the databases,
plasmid pSCEC2 was completely sequenced and the genetic environment of the cfr gene was analysed.
Materials and methods
Bacterial strain and susceptibility testing
Samples (n¼696) were collected from individual pigs (n ¼341 nasal swabs;
n¼102 lungs; n¼135 maxillary lymph nodes; n¼89 pericardial fluid
swabs) and pig farm environments (n ¼19 waste water; n¼10 soil) in
four unrelated pig farms in Sichuan province, south-west China from April
2010 to October 2011. Resistance to florfenicol was evaluated by growth
on MacConkey agar plates supplemented with 10 mg/L florfenicol for
18 h at 378C. A total of 311 Gram-negative bacilli that grew on these selective plates were subjected to screening for the cfr gene by PCR.9 A single E. coli
isolate, designated SCEC2, from the maxillary lymph node of a sick pig was
positive for cfr. The antimicrobial susceptibility profiles of the original strain
SCEC2 and its transconjugant were determined using broth microdilution
according to CLSI recommendations.10 The following antimicrobial
agents were tested with the test ranges in mg/L given in parentheses: ampicillin (0.125–256), florfenicol (0.125–256), tetracycline (0.125– 128), amikacin (0.06–64), kanamycin (0.25–256), gentamicin (0.06–64), streptomycin
(0.25–256), sulfisoxazole (0.25–256) and enrofloxacin (0.006–64). E. coli
ATCC 25922 served as a quality-control strain.
Conjugation, plasmid sequencing and sequence analysis
Plasmid profiling was conducted using a Qiagen Plasmid Midi Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s instructions. E. coli
SCEC2 was subjected to conjugation via filter mating with the sodium
azide-resistant E. coli strain J53 as the recipient, following the procedure
described previously.11 Transconjugants were selected on brain heart infusion agar supplemented with 100 mg/L sodium azide and 10 mg/L florfenicol. Plasmid DNA was purified from the E. coli J53 transconjugant using the
aforementioned kit.
Plasmid pSCEC2 was sequenced using the 454 Life Sciences (Roche)
GS-FLX System. The gaps between the contigs were closed by PCR and the respective amplicons were sequenced. Sequence data were assembled using
SeqMan software from DNAStar (Lasergene, Madison, WI, USA). The putative
coding sequences (CDSs) were identified using the ORF Finder program (http
://www.ncbi.nlm.nih.gov/projects/gorf/). The Vector NTI program (Invitrogen,
Carlsbad, CA, USA) was used to annotate the whole plasmid sequence,
and sequence comparison was performed using BLASTN and BLASTP
(http://blast.ncbi.nlm.nih.gov), ClustalW2 (http://www.ebi.ac.uk/Tools/msa/
clustalw2) and VISTA (http://genome.lbl.gov/vista/mvista/submit.shtml).
An inverse PCR using the primers cfrIF (5′ -TGAAGTCTGCTGGTATCCATGT-3′ )
and cfrIR (5′ -TTTGCTCTGCTAAGAGCTTGAT-3′ ) was applied as previously
described9 to see whether minicircles containing the cfr gene and one insertion sequence are formed from plasmid pSCEC2.
The complete nucleotide sequence of plasmid pSCEC2 has been deposited in GenBank under accession number KF152885.
Results and discussion
Size and structure of plasmid pSCEC2
Plasmid profiling identified seven plasmids in E. coli SCEC2, of which
only the 135 kb plasmid, designated pSCEC2, was detected in the
transconjugant. Comparative susceptibility testing of E. coli J53
and its transconjugant carrying pSCEC2 revealed that this
plasmid conferred resistance to tetracycline (MIC 128 mg/L) and
386
sulphonamides (MIC 256 mg/L) and high MICs (≥512 mg/L) of
streptomycin and florfenicol, respectively. Determination of the
complete sequence of the conjugative plasmid pSCEC2 revealed
a size of 135 615 bp (Figure 1a). Analysis of the sequence identified
200 open reading frames (ORFs) for proteins of ≥100 amino acids.
Among them, only the products of 66 ORFs exhibited high similarities to proteins with known functions—mainly plasmid replication,
conjugative transfer, plasmid maintenance and antimicrobial resistance (Table S1, available as Supplementary data at JAC Online).
The pSCEC2 backbone of 120613 bp shows high homology
with that of the IncA/C plasmid pR55 from a human Klebsiella
pneumoniae strain isolated in 1969 in France12 and other E. coli
IncA/C plasmids of animal origin, such as pPG010208 (GenBank
accession number HQ023861),13 pAR060302 (GenBank accession
number FJ621588),14 pUMNK88_161 (GenBank accession number
HQ023862)13 and p199061_160 (GenBank accession number
HQ023863)13 (Figure 1b). As suggested by previous analysis,13
the core sequence of pSCEC2 can be divided into three regions: (i)
IncA/C replicon, with the plasmid replication gene repA; (ii) a conjugative transfer-associated region Tra1; and (iii) a conjugative
transfer-associated region Tra2 (Figure 1b).
Analysis of the regions containing resistance genes
The average GC content of pSCEC2 is 51.4%, which is similar to that
of other sequenced IncA/C plasmids (46.0% –53.1%). Plasmid
pSCEC2 carried two accessory resistance gene regions that differed
in their GC content from that of the backbone (Figure 1a).
The first accessory region of 9602 bp had a relatively high
GC content of 59.8% and contained the genes floR for phenicol
resistance, tet(A)-tetR for tetracycline resistance, strA/strB for
streptomycin resistance and sul2 for sulphonamide resistance
(Figure 1a). Similar resistance gene regions have been detected in
other sequenced IncA/C plasmids, i.e. pAM04528, pPG010208,
pAR060302, pUMNK88_161, p199061_160 and peH4H. An ISCR2
insertion sequence was located immediately upstream of the
floR gene. Moreover, the floR resistance gene cluster or only the
genes sul2 and floR were found to be associated with ISCR2 in numerous genetic contexts,15 which gives credence to speculations
about the ability of ISCR2 to mobilize adjacent resistance genes
or gene clusters.
The second accessory region of 4463 bp had a distinctly lower
GC content of 33.7% and hence had likely been acquired from
Gram-positive bacteria. This segment contained the multiresistance gene cfr flanked by two identical copies of the 1324 bp
IS256 element located in the same orientation. It should be
noted that IS256 is a common insertion sequence present in
both chromosomal DNA and plasmids among Gram-positive
cocci, but has been seen rarely among E. coli and other Enterobacteriaceae.16 Immediately downstream of the left IS256 and
upstream of the right IS256, 8 bp direct target site duplications
(5′ -AAAAAAAC-3′ ) were found (Figure 2). However, further sequences downstream of the left and upstream of the right IS256
element displayed .99% nucleotide sequence identity with the
corresponding regions of the IncA/C plasmid pPG010208 from
E. coli.13 Regions composed of cfr and associated insertion
sequences, e.g. IS21-558, IS1216, ISEnfa4 (formerly known as
IS256-like) or ISEnfa5 have been identified previously on plasmids
of Enterococcus spp., S. suis and Staphylococcus spp.5,6 The
cfr-carrying plasmid pBS-02 from Bacillus9 had a 3036 bp
cfr-carrying E. coli IncA/C plasmid pSCEC2
JAC
(a)
(b)
Figure 1. (a) Circular representation of the IncA/C plasmid pSCEC2. The circles display (from the outside inwards): (i) the size in bp; (ii) the position of
predicted coding sequences transcribed in the clockwise orientation; (iii) the position of predicted coding sequences transcribed in the anticlockwise
orientation; (iv) the GC content plotted against 50%, with blue indicating .50% and red indicating ,50%; and (v) GC skew [(G+C)/(G 2C)] in a 500 bp
window. Genes are colour-coded, depending on functional annotations: pink, plasmid replication/maintenance/modification; green, transposition/
recombination; blue, conjugative transfer; red, antimicrobial resistance; and grey, other putative functions/hypothetical proteins. (b) Sequence
comparisons of pSCEC2 with other completely or in part sequenced IncA/C plasmids: pR55 (K. pneumoniae, France, 1969, accession number
JQ010984); pPG010208 (E. coli, Chile, 2004, accession number HQ023861); pAR060302 (E. coli, USA, 2002, accession number FJ621588);
pUMNK88_161 (E. coli, 2007, USA, accession number HQ023862); and p199061_160 (E. coli, 1995, USA, accession number HQ023863). The scale of
identity is shown on the right. The transcription direction of selected genes in pR55 is shown by arrows, with tra genes indicated by abbreviation to the
corresponding capital letters. The core sequences are coloured orange (IncA/C replicon and hypothetical genes), pink (Tra1 region) and green (Tra2
region). The figure was drawn using mVISTA (http://genome.lbl.gov/vista/mvista/submit.shtml) using a calculation window of 100 bp.
387
Zhang et al.
Figure 2. Genetic environment of the cfr gene in IncA/C plasmid pSCEC2 and structural comparison with pPG010208 from E. coli of bovine origin and pBS-02
from Bacillus spp. of swine origin. The positions and orientations of the genes are indicated by arrows, with the direction of transcription shown by the
arrowhead. Grey shading indicates ≥99.9% nucleotide sequence identity. The 8 bp direct target site duplication sequence is boxed. The positions and
orientations of the reverse PCR primers used to test the stability of the cfr region in pSCEC2 are indicated by black arrows.
segment in common (99.9% nucleotide sequence identity) with
pSCEC2, which contained the cfr gene and downstream of it an
IS256 element (Figure 2). In plasmid pSCEC2, the 367 bp upstream
region of cfr that includes the predicted cfr promoter sequence
closely matched the corresponding sequence of plasmids pSCFS1
and pBS-02, except for a 51 bp variation at the 5′ end of ORF1,
which resulted in the loss of the N-terminal 17 amino acids of
ORF1 (Figure 2).
In principle, two options exist for how this 4447 bp segment,
containing cfr and two IS256 elements, was integrated into
plasmid pSCEC2. The first option is a single-step process that postulates that the segment represents a small composite transposon. This transposon can excise from its former location and
integrate in new locations on either plasmids or chromosomal
DNA, and thereby produce the typical 8 bp direct repeats at its integration site. The second option is a double-step process that postulates that the integration of a single copy of IS256, which
produced the characteristic 8 bp direct repeats, occurred first. In
a second step, a recombination between this IS256 and a minicircle
comprising cfr and another copy of IS256 has occurred. This finally
led to the integrated cfr gene being flanked by two copies of IS256
that are located in the same orientation. The formation of minicircles that carry cfr plus one copy of an insertion sequence,
e.g. IS1216 or ISEnfa5 in Enterococcus and Streptococcus spp.
and IS21-558 and ISEnfa4 in Staphylococcus spp. has been
described.5,6 Moreover, the PCR-based stability test using primers
of cfrIF and cfrIR (Figure 2) also revealed that the cfr gene and
one IS256 element could easily be excised from plasmid pSCEC2,
suggesting that cfr may be transferable by IS256-mediated recombination.
to acquire different resistance genes, they have already been
considered to pose a serious challenge to anti-infective
therapy in human and veterinary medicine.17 In this study,
an IncA/C plasmid carrying the multiresistance gene cfr
flanked by two copies of IS256 was described for the first time in
a porcine E. coli strain. The presence of resistance genes in
Gram-negative bacteria that presumably originated from Grampositive bacteria is apparently more widespread than assumed.
This refers mainly to genes that confer resistance to tetracyclines
and macrolides, such as tet(M), tet(L), erm(B) and mef(A)msr(D).18 – 21 The location of the cfr gene on a conjugative
broad-host-range plasmid paves the way for its further dissemination to susceptible bacteria and potential reintroduction into
the Gram-positive gene pool. Further surveillance is thus necessary
to determine the prevalence of cfr-carrying IncA/C plasmids
among Gram-negative bacteria from humans and animals and
to monitor their dissemination.
Funding
This work was supported by grants from the National Natural Science Foundation of China (No. 31201862), the national ‘973’ program (No.
2012CB518801), the Central Public-interest Scientific Institution Basal Research Fund (No. 0302013014) and the China Postdoctoral Science Foundation (No. 2012M520482 and No. 2013T60204). The contribution of S. S. was
funded by the German Federal Ministry of Education and Research (BMBF),
grant Nos 01KI1013A (RESET) and 01KI1014D (MedVet-Staph).
Conclusions
As broad-host-range plasmids of the IncA/C family are widely disseminated among Gram-negative bacteria and have been shown
388
Transparency declarations
None to declare.
cfr-carrying E. coli IncA/C plasmid pSCEC2
Supplementary data
JAC
From Animals—Third Edition: Approved Standard M31-A3. CLSI, Wayne, PA,
USA, 2008.
Table S1 is available as Supplementary data at JAC Online (http://jac.
oxfordjournals.org/).
11 Zhang WJ, Lu Z, Schwarz S et al. Complete sequence of the blaNDM-1carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal
origin. J Antimicrob Chemother 2013; 68: 1681 –2.
References
12 Doublet B, Boyd D, Douard G et al. Complete nucleotide sequence of the
multidrug resistance IncA/C plasmid pR55 from Klebsiella pneumoniae
isolated in 1969. J Antimicrob Chemother 2012; 67: 2354 –60.
1 Long KS, Poehlsgaard J, Kehrenberg C et al. The Cfr rRNA methyltransferase
confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins,
and streptogramin A antibiotics. Antimicrob Agents Chemother 2006; 50:
2500–5.
2 Calfee DP. Methicillin-resistant Staphylococcus aureus and vancomycinresistant enterococci, and other Gram-positives in healthcare. Curr Opin
Infect Dis 2012; 25: 385–94.
3 Flamm RK, Mendes RE, Ross JE et al. An international activity and
spectrum analysis of linezolid: ZAAPS Program results for 2011. Diagn
Microbiol Infect Dis 2013; 76: 206–13.
4 Feßler AT, Calvo N, Gutiérrez N et al. Cfr-mediated linezolid resistance in
methicillin-resistant Staphylococcus aureus and Staphylococcus haemolyticus
associated with clinical infections in humans: two case reports. J Antimicrob
Chemother 2014; 69: 268–270.
13 Fernandez-Alarcon C, Singer RS, Johnson TJ. Comparative genomics of
multidrug resistance-encoding IncA/C plasmids from commensal and
pathogenic Escherichia coli from multiple animal sources. PLoS One 2011;
6: e23415.
14 Call DR, Singer RS, Meng D et al. blaCMY-2-positive IncA/C plasmids from
Escherichia coli and Salmonella enterica are a distinct component of a larger
lineage of plasmids. Antimicrob Agents Chemother 2010; 54: 590– 6.
15 Toleman MA, Bennett PM, Walsh TR. ISCR elements: novel genecapturing systems of the 21st century? Microbiol Mol Biol Rev 2006; 70:
296–316.
16 Hennig S, Ziebuhr W. Characterization of the transposase encoded by
IS256, the prototype of a major family of bacterial insertion sequence
elements. J Bacteriol 2010; 192: 4153–63.
5 Shen J, Wang Y, Schwarz S. Presence and dissemination of the
multiresistance gene cfr in Gram-positive and Gram-negative bacteria.
J Antimicrob Chemother 2013; 68: 1697– 706.
17 Fricke WF, Welch TJ, McDermott PF et al. Comparative genomics of the
IncA/C multidrug resistance plasmid family. J Bacteriol 2009; 191: 4750– 7.
6 Wang Y, Li D, Song L et al. First report of the multiresistance gene cfr in
Streptococcus suis. Antimicrob Agents Chemother 2013; 57: 4061– 3.
18 Ojo KK, Ruehlen NL, Close NS et al. The presence of a conjugative
Gram-positive Tn2009 in Gram-negative commensal bacteria. J Antimicrob
Chemother 2006; 57: 1065–9.
7 Wang Y, Wu CM, Schwarz S et al. Detection of the staphylococcal
multiresistance gene cfr in Proteus vulgaris of food animal origin. J Antimicrob
Chemother 2011; 66: 2521–6.
8 Wang Y, He T, Schwarz S et al. Detection of the staphylococcal
multiresistance gene cfr in Escherichia coli of domestic-animal origin.
J Antimicrob Chemother 2012; 67: 1094 – 8.
9 Zhang WJ, Wu CM, Wang Y et al. The new genetic environment of cfr on
plasmid pBS-02 in a Bacillus strain. J Antimicrob Chemother 2011; 66:
1174– 5.
10 Clinical and Laboratory Standards Institute. Performance Standards
for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated
19 Ojo KK, Ulep C, Van Kirk N et al. The mef(A) gene predominates among
seven macrolide resistance genes identified in Gram-negative strains
representing 13 genera, isolated from healthy Portuguese children.
Antimicrob Agents Chemother 2004; 48: 3451– 6.
20 Hu GZ, Pan YS, Wu H et al. Prevalence of tetracycline resistance genes
and identification of tet(M) in clinical isolates of Escherichia coli from sick
ducks in China. J Med Microbiol 2013; 62: 851– 8.
21 Kehrenberg C, Catry B, Haesebrouck F et al. tet(L)-mediated tetracycline
resistance in bovine Mannheimia and Pasteurella isolates. J Antimicrob
Chemother 2005; 56: 403– 6.
389